Target intelligence / Profile preview

microRNA 548as (miR-548as)

Target
miR-548as
Molecular classification
Other (microRNA)
01

Overview

microRNA 548as (miR-548as, hsa-mir-548as, MIR548AS) is a member of the large, **primate-specific miR-548 microRNA gene family**[2][4]. MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression post-transcriptionally by binding to complementary sequences in target messenger RNAs (mRNAs), resulting in translational repression or mRNA degradation[3]. The miR-548 family influences numerous biological pathways, including proliferation, apoptosis, immune signaling, and cancer-related pathways[1][2][4]. miR-548ah (a closely related family member) has been shown to target key immune receptors, such as IFN-γR1, suppressing immune responses and playing a role in viral pathogenesis and immune regulation in chronic hepatitis B[1]. Various members of the miR-548 family, including miR-548a-5p, have been implicated in the regulation of **tumor suppressor genes (e.g., Tg737)** and have functional roles in hepatocellular carcinoma and other cancers by modulating cell cycle, proliferation, and apoptosis[2]. Expression levels of miR-548 family members have shown utility as biomarkers for disease states, particularly in cancer and cardiovascular disease[2][3]. There is currently no evidence that miR-548as itself is a *direct therapeutic target* (such as a receptor, enzyme, transporter, or ion channel), and it is more accurately described as a *regulatory RNA molecule* or a disease biomarker[2][3][4]. **Important note:** There is insufficient public characterization of the specific miR-548as (MIR548AS, hsa-mir-548as) variant in peer-reviewed sources; most detailed studies refer to related members of the miR-548 family (miR-548ah, miR-548a-5p, miR-548d-3p, etc.), some of which are sometimes inconsistently labeled. The core features described above reflect the overall biology and known functions of the miR-548 family[2][4]. If you require information about a specifically validated therapeutic target, miR-548as would not be classified as such at this time.

Other names
hsa-mir-548asMIR548ASmicroRNA-548as
02

Biological functions

Gene regulationSignal transductionCell proliferationApoptosisImmune response
03

Disease associations

CancerViral infection (Hepatitis B, hepatitis C, HIV-1)Cardiovascular disease (biomarker in heart failure)Immune-related disease
04

Safety considerations

Off-target gene regulationunclear systemic effectslack of validated specificity
05

Biomarkers

miR-548 (including miR-548ah and a-5p subtypes) has been reported as a potential biomarker for cardiomyopathies and cancer progression[2][3].

Beyond the preview

Go deeper on microRNA 548as (miR-548as).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 548as (miR-548as).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call